Best Disease

Best disease, also known as vitelliform macular dystrophy, is an inherited eye disorder that primarily affects the macula—the part of the retina responsible for central, detailed vision. It is characterized by the accumulation of yellowish, egg-yolk–like deposits (lipofuscin) beneath the retinal pigment epithelium, leading to progressive deterioration of central vision. The condition usually appears in childhood or adolescence, although onset and severity can vary widely among individuals MedlinePlusWikipedia.

Best disease, also known as Best vitelliform macular dystrophy, is a rare, inherited eye disorder that affects the macula—the central part of the retina responsible for sharp, straight-ahead vision. It usually begins in childhood or adolescence and leads to a yellowish, egg-yolk–like lesion in the macula, which over time can break down and cause vision loss. Best disease is caused by mutations in the BEST1 gene, which encodes a protein called bestrophin-1, essential for normal ion transport in the retinal pigment epithelium (RPE). When bestrophin-1 malfunctions, waste products accumulate beneath the RPE, forming characteristic lesions that gradually impair central vision. Although there is no cure, early diagnosis and management can help preserve vision and quality of life.

---

Types of Best Disease

Juvenile Best Vitelliform Macular Dystrophy (BVMD)
Juvenile BVMD is the classic form of Best disease, typically manifesting in children between 5 and 15 years of age. Clinically, it is marked by distinct “vitelliform” lesions in the macula that resemble an egg yolk. Although it follows an autosomal dominant inheritance pattern, expressivity can vary significantly, resulting in a range of lesion sizes and degrees of visual impairment Wikipedia.

Adult-Onset Vitelliform Macular Dystrophy (AVMD)
Adult-onset vitelliform dystrophy presents later in life, usually between 40 and 60 years of age. It tends to cause milder and more slowly progressive vision loss compared to the juvenile form. Unlike juvenile BVMD, fewer than 25% of AVMD cases are linked to BEST1 gene mutations; many cases arise sporadically, and the exact genetic or environmental causes remain under investigation Nature.

Autosomal Recessive Bestrophinopathy (ARB)
ARB is a less common form of bestrophinopathy inherited in an autosomal recessive manner, often due to biallelic mutations in the BEST1 gene. It can present anywhere from early childhood to later life with a range of symptoms, including widespread retinal pigment epithelium abnormalities, subretinal fluid accumulation, and potential complications such as angle-closure glaucoma. ERG and EOG findings are typically more severely abnormal than in BVMD jocmr.org.

---

Causes of Best Disease

Best disease is fundamentally caused by pathogenic variants in the BEST1 gene, which provides instructions for producing the bestrophin-1 protein in retinal pigment epithelial cells. Bestrophin-1 functions as a chloride channel, regulating fluid and ion transport across the RPE. Mutations disrupt channel activity, leading to lipofuscin accumulation and progressive macular degeneration. Over 100 distinct BEST1 mutations have been identified, predominantly following an autosomal dominant inheritance pattern in BVMD MedlinePlusWikipedia.

1. Missense Mutations
   Single-nucleotide changes in the BEST1 gene that result in amino acid substitutions within the bestrophin-1 protein can alter protein folding or channel properties. These missense mutations are the most common and lead to dysfunctional chloride transport in the RPE Wikipedia.

2. Nonsense Mutations
   Variants introducing a premature stop codon produce truncated bestrophin-1 proteins, which are often nonfunctional and degraded by quality-control pathways, worsening ion channel deficits in retinal cells Wikipedia.

3. Frameshift Insertions
   Insertion of nucleotides that shifts the gene’s reading frame yields entirely different amino acid sequences downstream, rendering the resulting bestrophin-1 proteins nonfunctional and compromising chloride transport Wikipedia.

4. Frameshift Deletions
   Deletions not in multiples of three also disrupt the reading frame, producing aberrant proteins that cannot integrate properly into the RPE membrane, leading to severe channel impairment MedlinePlus.

5. In-Frame Deletions
   Removal of nucleotides in multiples of three deletes specific amino acids without altering the downstream reading frame. Such deletions can destabilize protein structure or impair channel gating depending on their location MedlinePlus.

6. In-Frame Insertions
   Insertions of nucleotides in multiples of three add extra amino acids into the protein, which can perturb local folding or channel pore architecture of bestrophin-1, reducing its chloride transport effectiveness MedlinePlus.

7. Splice-Site Mutations
   Variants affecting intron-exon boundaries can lead to aberrant mRNA splicing, resulting in exon skipping or intron retention. Mis-splicing may create truncated or misfolded proteins that fail to function Wikipedia.

8. Copy Number Variations
   Duplication or deletion of segments of the BEST1 gene can alter gene dosage, either increasing or decreasing bestrophin-1 production. Both scenarios disrupt chloride channel balance in the retina MedlinePlus.

9. Large Genomic Deletions
   Deletions encompassing multiple exons or the entire gene result in absence of functional bestrophin-1, typically causing severe phenotypes in ARB when both alleles are affected jocmr.org.

10. Compound Heterozygosity
    Inheriting two different pathogenic variants—one on each allele—can produce ARB, where each variant contributes partial loss of bestrophin-1 function that, combined, results in disease jocmr.org.

11. Mosaicism
    Post-zygotic mutations may lead to a subset of retinal cells harboring a BEST1 mutation, resulting in mosaic expression of dysfunction. Disease severity varies with the proportion and distribution of affected cells MedlinePlus.

12. Gain-of-Function Mutations
    Some BEST1 variants increase channel activity or alter ion selectivity, causing cellular stress and lipofuscin buildup despite increased ion flow. These rare gain-of-function effects add to disease heterogeneity ncophth.com.

13. Loss-of-Function Mutations
    Variants that reduce or abolish bestrophin-1 channel activity lead to ion homeostasis imbalance across the RPE, causing photoreceptor dysfunction and toxic byproduct accumulation Wikipedia.

14. Dominant-Negative Mutations
    Certain mutant bestrophin-1 proteins assemble with normal proteins, impairing entire channel complexes. This dominant-negative interference often results in more severe macular dystrophy MedlinePlus.

15. Genetic Modifier Influence
    Variations in other genes or regulatory regions—such as PRPH2—can modify disease onset and severity in BEST1 mutation carriers, underscoring the role of additional genetic factors in Best disease phenotypes Wikipedia.

---

Symptoms of Best Disease

1. Decreased Visual Acuity
   A drop in sharpness of vision, measured as visual acuity, is often the first sign. Central vision impairment may progress slowly over years and is detected during routine eye exams Cleveland Clinic.

2. Metamorphopsia
   Distortion of straight lines into wavy or bent shapes results from irregularities in the macular surface caused by vitelliform lesions, making tasks like reading challenging Cleveland Clinic.

3. Central Scotoma
   Dark or blind spots at the center of the visual field—central scotomas—correspond to areas where photoreceptor cells cannot capture light due to RPE damage mdfoundation.com.au.

4. Color Vision Deficiency
   Impaired cone photoreceptor support in the macula can lead to red-green color discrimination difficulties, affecting tasks that require accurate color perception Foundation Fighting Blindness.

5. Photophobia
   Increased sensitivity to bright light occurs as retinal cells become exposed to unregulated light levels due to dysfunctional RPE support ncophth.com.

6. Difficulty Reading
   Central vision loss and distortion make fine print hard to read, impacting educational performance and daily activities for affected youth RNIB.

7. Micropsia
   Objects may appear smaller than they are—micropsia—due to macular stretching and distortion from subretinal fluid or lipofuscin accumulation mdfoundation.com.au.

8. Yellowish Macular Lesions
   Bright yellow deposits beneath the macula form distinctive “egg-yolk” lesions, a hallmark of Best disease observed during fundus examination National Organization for Rare Disorders.

9. Vitelliruptive Phase Changes
   In the vitelliruptive stage, the central lesion ruptures, causing mixed fluid and pigment appearance and fluctuating vision quality NCBI.

10. Macular Atrophy and Fibrosis
    Progressive degeneration of the RPE and photoreceptors leads to atrophic or fibrotic macular changes, culminating in permanent central vision loss BioMed Central.

---

Diagnostic Tests for Best Disease

Physical Examination

1. Visual Acuity Test
   Measurement of the smallest letters or symbols a person can read on a standardized chart at a set distance helps identify central vision loss due to macular lesions Verywell Health.

2. Intraocular Pressure (Tonometry)
   Tonometry assesses eye pressure; elevated pressure can arise secondarily in some bestrophinopathy cases due to angle-closure mechanisms Verywell Health.

3. Pupillary Light Reflex
   Testing direct and consensual pupil responses to light evaluates afferent and efferent visual pathways, which may be subtly altered in extensive retinal disease Wikipedia.

Manual Tests

4. Amsler Grid
   Viewing a grid of straight lines helps detect metamorphopsia or scotomas; distortions or missing lines indicate central macular dysfunction Cleveland Clinic.

5. Color Vision Plates
   Standardized tests such as Ishihara plates reveal red-green color deficiencies resulting from cone photoreceptor impairment in the macula Foundation Fighting Blindness.

6. Slit-Lamp Biomicroscopy
   A slit-lamp microscope with fundus lens allows detailed visualization of the macular lesions and RPE changes under high magnification mdfoundation.com.au.

Laboratory and Pathological Tests

7. Genetic Sequencing of BEST1
   Molecular analysis of the BEST1 gene confirms the diagnosis by identifying pathogenic variants and informs genetic counseling on inheritance patterns MedlinePlus.

8. Bestrophin-1 Functional Assay
   In vitro assays assessing chloride channel activity in cells expressing mutant bestrophin-1 help correlate specific mutations with functional impairment MedlinePlus.

9. Basic Metabolic Blood Tests
   Routine laboratory panels exclude systemic or metabolic disorders that might mimic macular dystrophy phenotypes, ensuring accurate diagnosis MedlinePlus.

10. Retinal Tissue Histopathology
    Though rare, research-grade RPE biopsy and histological staining reveal lipofuscin deposits and confirm RPE degeneration, supporting clinical findings BioMed Central.

Electrodiagnostic Tests

11. Electrooculography (EOG)
    EOG measures the standing potential across the RPE. A reduced Arden ratio (<1.5) is pathognomonic for Best disease and is the most sensitive diagnostic test Review of Optometry.

12. Full-Field Electroretinography (ERG)
    ERG evaluates overall retinal electrical responses. In BVMD, full-field ERG is often normal, distinguishing it from dystrophies with diffuse retinal dysfunction Review of Optometry.

13. Multifocal ERG (mfERG)
    mfERG maps localized retinal responses, detecting macular dysfunction even when full-field ERG appears normal by highlighting areas of decreased electrical activity Review of Optometry.

14. Visual Evoked Potentials (VEP)
    VEP assesses conduction along visual pathways to the cortex, detecting delays related to macular degeneration and providing supplementary diagnostic information Foundation Fighting Blindness.

Imaging Tests

15. Optical Coherence Tomography (OCT)
    OCT produces high-resolution cross-sectional images of retinal layers. In Best disease, it reveals a hyperreflective vitelliform deposit under photoreceptors and subsequent photoreceptor thinning NCBI.

16. Fundus Autofluorescence (FAF)
    FAF captures autofluorescent signals from lipofuscin in the RPE. Vitelliform lesions appear as areas of increased autofluorescence, correlating with disease activity Review of Optometry.

17. Fundus Photography
    Color fundus images document the characteristic yellow macular lesions, enabling longitudinal monitoring of lesion progression and atrophic changes BioMed Central.

18. Fluorescein Angiography (FFA)
    Intravenous fluorescein dye highlights retinal and choroidal vessels. In Best disease, window defects from RPE atrophy produce hyperfluorescent areas without dye leakage BioMed Central.

19. Indocyanine Green Angiography (ICGA)
    ICGA uses infrared-excited dye to image deeper choroidal vessels. It helps detect complications such as choroidal neovascularization and distinguish Best disease from other maculopathies Wikipedia.

20. Adaptive Optics Scanning Laser Ophthalmoscopy (AOSLO)
    AOSLO delivers ultrahigh-resolution images of photoreceptor mosaics, revealing cone cell distribution and guiding research on early photoreceptor changes in Best disease Wikipedia.

Non-Pharmacological Treatments

Below are 20 evidence-based, non-drug approaches—covering exercise therapies, mind-body techniques, and educational self-management—that help people with Best disease maintain visual function and cope with vision changes.

1. Low Vision Rehabilitation
   Description: Customized training with low-vision specialists to use remaining vision effectively.
   Purpose: Improve independence in daily tasks such as reading, cooking, and personal care.
   Mechanism: Teaches use of magnifiers, telescopic lenses, and adaptive strategies to maximize residual macular vision.

2. Eccentric Viewing Training
   Description: Exercises that train patients to look slightly away from their central scotoma.
   Purpose: Help use healthier parts of the retina for clearer vision.
   Mechanism: Through guided practice, patients learn to position objects in the peripheral retina, bypassing the damaged macula.

3. Microperimetry Biofeedback
   Description: A computer-guided program providing real-time feedback on fixation stability.
   Purpose: Enhance control over eye movements and fixation precision.
   Mechanism: Auditory or tactile cues reinforce use of more stable retinal loci for clearer focus.

4. Vision Therapy Exercises
   Description: Tailored eye-movement and focusing drills with a vision therapist.
   Purpose: Improve coordination between eyes and strengthen peripheral vision use.
   Mechanism: Repetitive visual tasks stimulate neural adaptation and optimize binocular vision.

5. Contrast Sensitivity Training
   Description: Tasks that involve detecting low-contrast letters or shapes under therapy.
   Purpose: Enhance ability to see subtle differences in shades and outlines.
   Mechanism: Repeated exposure to contrast-varied stimuli encourages the visual system to sharpen contrast perception.

6. Adaptive Lighting and Environmental Modifications
   Description: Adjusting room lighting, reducing glare, using high-contrast colors on walls and work surfaces.
   Purpose: Create an environment that minimizes visual strain and maximizes comfort.
   Mechanism: Optimal lighting levels and contrast reduce the workload on partially functioning photoreceptors.

7. Occupational Therapy
   Description: Training in daily living skills, from handling kitchen tools to using electronic devices.
   Purpose: Promote independence and safety at home and work.
   Mechanism: Therapists teach adaptive techniques, such as tactile markers on appliances or voice-controlled technology.

8. Assistive Technology Use
   Description: Incorporating screen-reading software, electronic magnifiers, and text-to-speech apps.
   Purpose: Facilitate reading, writing, and digital communication.
   Mechanism: Technology compensates for reduced visual acuity by enlarging text or converting it to audio format.

9. Amsler Grid Monitoring
   Description: Daily self-testing grid that detects subtle changes in central vision.
   Purpose: Early identification of lesion progression or complications like choroidal neovascularization.
   Mechanism: By noticing grid line distortions or missing areas, patients can promptly report changes to their doctor.

10. Yoga and Relaxation Techniques
    Description: Gentle yoga postures, deep-breathing exercises, and guided relaxation.
    Purpose: Reduce stress and improve overall well-being, which may indirectly benefit eye health.
    Mechanism: Lowers cortisol levels and promotes blood flow, potentially supporting retinal function.

11. Mindfulness Meditation
    Description: Practices focusing on present-moment awareness and nonjudgmental observation.
    Purpose: Help cope with anxiety or depression related to vision loss.
    Mechanism: Regular meditation reshapes neural circuits involved in emotional regulation, enhancing psychological resilience.

12. Progressive Muscle Relaxation
    Description: Systematic tensing and relaxing of muscle groups from head to toe.
    Purpose: Relieve tension that can accompany visual strain.
    Mechanism: Physical relaxation feedback diminishes sympathetic arousal, improving comfort during visual tasks.

13. Educational Self-Management Workshops
    Description: Group classes covering disease basics, coping strategies, and resource navigation.
    Purpose: Empower patients with knowledge to manage Best disease proactively.
    Mechanism: Structured learning enhances adherence to visual aids, monitoring routines, and lifestyle modifications.

14. Peer Support Groups
    Description: Meetings—online or in person—where individuals share experiences and tips.
    Purpose: Foster community support, reduce feelings of isolation.
    Mechanism: Social connection and shared learning improve motivation and mental health in chronic disease management.

15. Stress Management Counseling
    Description: One-on-one sessions with a trained counselor or psychologist.
    Purpose: Address emotional challenges posed by progressive vision loss.
    Mechanism: Cognitive-behavioral techniques reframe negative thoughts and teach coping skills.

16. Ergonomic Workplace Adjustments
    Description: Positioning screens at proper angles, using anti-glare filters, and adjusting font sizes.
    Purpose: Reduce eye fatigue during computer work.
    Mechanism: Minimizes glare and ensures comfortable viewing distance, preserving remaining vision.

17. Nutritional Counseling (Dietary Advice)
    Description: Guidance on a balanced diet rich in antioxidants and omega-3s.
    Purpose: Support overall eye health.
    Mechanism: Antioxidants neutralize free radicals; omega-3 fatty acids maintain retinal cell integrity.

18. Blue-Light Filtering Glasses
    Description: Spectacles that block or reduce high-energy blue light from screens.
    Purpose: Lessen potential retinal stress from prolonged screen exposure.
    Mechanism: Filters absorb blue wavelengths that may contribute to oxidative stress in photoreceptors.

19. Scheduled Rest Breaks
    Description: Follow the “20-20-20 rule”: every 20 minutes, look at something 20 feet away for 20 seconds.
    Purpose: Prevent eye strain and maintain focus.
    Mechanism: Shifts accommodative demand, allowing ciliary muscles to relax.

20. Genetic Counseling
    Description: Counseling sessions to discuss inheritance patterns and family planning.
    Purpose: Inform patients and families about risks of passing Best disease to children.
    Mechanism: Educates on autosomal dominant inheritance and options such as prenatal testing.

---

Pharmacological Treatments

While there is no approved drug that reverses Best disease, these medications may help manage complications or support retinal health. Dosages should be tailored by a retinal specialist.

1. Intravitreal Bevacizumab
   Class: Anti-VEGF monoclonal antibody
   Dosage & Timing: 1.25 mg injected into the vitreous every 4–6 weeks as needed for choroidal neovascularization.
   Side Effects: Endophthalmitis, increased intraocular pressure, injection discomfort.

2. Intravitreal Ranibizumab
   Class: Anti-VEGF fragment
   Dosage & Timing: 0.5 mg intravitreal injection monthly for active neovascular lesions.
   Side Effects: Eye pain, floaters, rare inflammation.

3. Intravitreal Aflibercept
   Class: VEGF trap fusion protein
   Dosage & Timing: 2 mg every 8 weeks after three initial monthly doses if CNV is present.
   Side Effects: Conjunctival hemorrhage, vitreous floaters.

4. Oral Acetazolamide
   Class: Carbonic anhydrase inhibitor
   Dosage & Timing: 250 mg twice daily for subretinal fluid reduction (off-label).
   Side Effects: Paresthesias, kidney stones, metabolic acidosis.

5. Oral Eplerenone
   Class: Mineralocorticoid receptor antagonist
   Dosage & Timing: 25 mg once daily (off-label) for chronic subretinal fluid.
   Side Effects: Hyperkalemia, dizziness.

6. Topical Bromfenac
   Class: NSAID eye drop
   Dosage & Timing: One drop twice daily for inflammation control around injection sites.
   Side Effects: Eye irritation, dryness.

7. Oral Lutein Capsules
   Class: Carotenoid supplement (see also “Dietary Supplements”).
   Dosage & Timing: 10 mg daily.
   Side Effects: Rare gastrointestinal upset.

8. Oral Zeaxanthin Capsules
   Class: Carotenoid supplement
   Dosage & Timing: 2 mg daily.
   Side Effects: None significant at recommended doses.

9. Oral Omega-3 Fatty Acids
   Class: Polyunsaturated fatty acid
   Dosage & Timing: 1 g DHA/EPA daily.
   Side Effects: Fishy aftertaste, mild GI discomfort.

10. Oral Vitamin E
    Class: Antioxidant
    Dosage & Timing: 400 IU daily.
    Side Effects: Rare bleeding risk at high doses.

---

Dietary Molecular Supplements

These supplements may support retinal cell health by reducing oxidative stress or providing nutritional cofactors.

1. Lutein (10 mg/day)
   Function: Filters harmful blue light.
   Mechanism: Accumulates in macula, absorbing high-energy photons.

2. Zeaxanthin (2 mg/day)
   Function: Supports macular pigment density.
   Mechanism: Associates with lutein to protect photoreceptors from photo-oxidation.

3. Docosahexaenoic Acid (DHA, 500 mg/day)
   Function: Maintains photoreceptor membrane fluidity.
   Mechanism: Integrates into retinal cell membranes, promoting neural transmission.

4. Eicosapentaenoic Acid (EPA, 500 mg/day)
   Function: Anti-inflammatory omega-3.
   Mechanism: Precursor to resolvins that dampen retinal inflammation.

5. Vitamin C (500 mg twice daily)
   Function: Water-soluble antioxidant.
   Mechanism: Neutralizes free radicals in retinal cells.

6. Vitamin E (400 IU/day)
   Function: Lipid-soluble antioxidant.
   Mechanism: Protects photoreceptor outer segments from lipid peroxidation.

7. Zinc (25 mg/day)
   Function: Cofactor for antioxidant enzymes.
   Mechanism: Stabilizes cell membranes and supports superoxide dismutase activity.

8. Copper (2 mg/day)
   Function: Essential for antioxidant enzyme function.
   Mechanism: Prevents copper-deficiency anemia when taking zinc supplements.

9. Anthocyanins (e.g., bilberry extract, 160 mg/day)
   Function: Improves night vision and vascular health.
   Mechanism: Scavenges reactive oxygen species in retinal capillaries.

10. Alpha-Lipoic Acid (300 mg/day)
    Function: Regenerates other antioxidants.
    Mechanism: Cycles between oxidized and reduced forms, supporting vitamin C and E activity.

---

Regenerative and Stem Cell Therapies

Experimental treatments aiming to replace or repair damaged retinal cells.

1. hESC-Derived RPE Cell Transplantation
   Dosage: ~200,000 cells injected subretinally in a scaffold.
   Function: Replace dysfunctional pigment epithelium.
   Mechanism: Transplanted RPE cells phagocytose waste and support photoreceptors.

2. iPSC-Derived RPE Implant
   Dosage: Patient-specific iPSC-RPE patch applied under retina.
   Function: Personalized cell therapy.
   Mechanism: Autologous cells reduce rejection risk, restoring RPE pump function.

3. Gene Therapy with AAV2-BEST1
   Dosage: Single subretinal injection of 1e10 vector genomes.
   Function: Deliver healthy BEST1 gene.
   Mechanism: Viral vector carries functional gene to RPE, improving ion transport.

4. CRISPR/Cas9-Mediated Gene Editing
   Dosage: Localized subretinal injection of editing complex.
   Function: Correct mutant BEST1 in situ.
   Mechanism: Endonuclease edits DNA, restoring normal protein production.

5. Mesenchymal Stem Cell (MSC) Intravitreal Injection
   Dosage: 1×10^6 MSCs in vitreous cavity.
   Function: Anti-inflammatory and trophic support.
   Mechanism: MSCs secrete growth factors that promote retinal cell survival.

6. Neurotrophic Factor Gene Delivery
   Dosage: AAV vector carrying ciliary neurotrophic factor (CNTF).
   Function: Protect photoreceptors.
   Mechanism: Sustained CNTF expression reduces apoptosis in degenerating retina.

---

Surgical Procedures

In selected cases, surgical interventions may help manage complications.

1. Vitrectomy with Subretinal Fluid Drainage
   Procedure: Removal of vitreous gel and drainage of excess fluid beneath retina.
   Benefits: Reduces serous detachment and may improve vision stability.

2. Macular Translocation Surgery
   Procedure: Entire macula is repositioned to healthier RPE area.
   Benefits: Places photoreceptors over functional RPE, potentially enhancing acuity.

3. Subretinal Gene Therapy Injection
   Procedure: Surgical delivery of viral vector under retina.
   Benefits: Targeted gene replacement with minimal off-target exposure.

4. RPE‐Choroid Patch Transplantation
   Procedure: Autologous RPE-choroid graft from peripheral retina placed under macula.
   Benefits: Restores RPE support layer, aiding photoreceptor survival.

5. Foveal Sparing Laser Photocoagulation
   Procedure: Low-energy laser to seal micro-leaks in choroidal vessels.
   Benefits: Controls neovascular growth without damaging central macula.

---

Prevention Strategies

1. Undergo early genetic counseling if family history is positive.

2. Perform annual dilated eye exams starting in childhood.

3. Use UV-blocking sunglasses outdoors.

4. Maintain a balanced, antioxidant-rich diet.

5. Avoid smoking and secondhand smoke.

6. Limit screen time and adhere to rest breaks.

7. Optimize indoor lighting and reduce glare.

8. Wear blue-light filtering lenses when using digital devices.

9. Monitor vision daily with an Amsler grid.

10. Keep systemic health in check (blood pressure, diabetes management).

---

When to See a Doctor

• Sudden changes in central vision (blurriness, blind spots)

• New distortions (lines appearing wavy)

• Dark spots in vision that appear overnight

• Increased light sensitivity or glare issues

• Signs of CNV such as rapid vision loss or metamorphopsia

Seek care promptly—ideally within 48 hours of noticing these changes—to address complications early.

---

What to Do and What to Avoid

What to Do:

1. Use prescribed vision aids daily.

2. Practice eccentric viewing exercises.

3. Take recommended supplements consistently.

4. Attend scheduled eye exams without fail.

5. Report any vision changes immediately.

What to Avoid:

1. Smoking or exposure to smoke.

2. Skipping rest breaks during screen use.

3. High-impact activities that risk eye injury.

4. Ignoring minor vision distortions.

5. Self-medicating without consulting an eye specialist.

---

Frequently Asked Questions

1. What exactly causes Best disease?
   Best disease is caused by mutations in the BEST1 gene. These mutations prevent the bestrophin-1 protein from regulating ion transport in the RPE, leading to waste buildup and macular lesions.

2. Is Best disease hereditary?
   Yes. It follows an autosomal dominant pattern—meaning a single copy of the mutated gene from one parent can cause the disorder.

3. At what age does Best disease start?
   Symptoms usually appear between childhood and early adulthood, often between ages 5 and 20, though some may not notice changes until later.

4. Can my child inherit Best disease?
   If one parent carries the mutated BEST1 gene, each child has a 50% chance of inheriting the condition.

5. Is there a cure for Best disease?
   Currently, there is no cure. Treatments focus on managing symptoms and complications, preserving vision as much as possible.

6. Will I go blind from Best disease?
   Total blindness is rare because peripheral vision generally remains intact. However, central vision loss can significantly affect reading and driving.

7. How is Best disease diagnosed?
   Diagnosis involves clinical eye exams, optical coherence tomography (OCT), electrooculography (EOG), and genetic testing for BEST1 mutations.

8. What is the role of electrooculography?
   EOG measures electrical responses of the RPE; a reduced Arden ratio is characteristic of Best disease.

9. Can gene therapy help?
   Gene therapy trials are underway and aim to introduce a healthy BEST1 gene into RPE cells, but this remains experimental.

10. Are anti-VEGF injections useful?
    They can treat secondary choroidal neovascularization that sometimes develops in Best disease, helping control fluid and bleeding.

11. Do vitamin supplements slow disease?
    Supplements like lutein, zeaxanthin, and omega-3s support retinal health but don’t halt genetic progression.

12. How often should I get my eyes checked?
    At minimum, once a year—or more frequently if your doctor notes active changes.

13. Can vision therapy really help?
    Yes. Techniques like eccentric viewing and microperimetry training improve functional use of remaining vision.

14. Should I adjust my diet?
    A diet rich in leafy greens, fish high in omega-3s, and antioxidants is recommended to support overall retinal health.

15. What lifestyle changes are most effective?
    Avoiding smoking, protecting eyes from UV and blue light, and adhering to rest breaks during near work all contribute to better long-term outcomes.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 14, 2025.